Formulation of shea butter Nanoparticle containing griseofulvin: a combination of antifungal and anti-inflammatory treatments

  • Sidy Mouhamed Dieng Université de Thiès, laboratoire de pharmacie galénique & industrielle, UFR santé de Thiès, Thies, Sénégal Cité Malick SY BP 967 Thiès
  • Madieye Séne Université cheikh Anta Diop de Dakar, laboratoire de pharmacologie et pharmacodynamie, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Ahmedou Bamba Koueimel Fall Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Moussa Diop Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Papa Mady Sy Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Louis Augustin Diaga Diouf Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Alphonse Rodrigue Djiboune Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Mamadou Soumboundou Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Gora Mbaye Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Mounibé Diarra Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Oumar Thioune Université de Thiès, laboratoire de pharmacie galénique & industrielle, UFR santé de Thiès, Thies, Sénégal Cité Malick SY BP 967 Thiès

Abstract

Nanomedicine has been a booming industry with the development of nanovectors to encapsulate water-soluble or amphiphilic molecules for drug delivery. As the new therapeutic agents synthesized are increasingly lipophilic, the development of new nanoparticulate vectors allowing their transport and targeting is now a major challenge. These particles are lipid nanoparticles, a few hundred nanometers in diameter, stabilized by a layer of surfactants composed of castor oil and stealth agents. Solid lipid nanoparticles based on shea butter, stabilized by cremophor® ELP, encapsulating griseofulvin, were formulated by the temperature phase inversion method. The shea butter nanoparticles thus obtained were the subject of characterization relating to: determination of the morphology, size, polydispersity index, pH and zeta potential. The results confirm the stability of our preparations. The anti-inflammatory activity of shea butter being known, the tests were carried out on mice. The inflammation was induced by a solution of croton oil acetone. There is a very big improvement in anti-inflammatory activity. This is due to better penetration of the preparation through the different layers of the skin. Griseofulvin release studies have been carried out on our various preparations. Systems designed as reservoirs of active ingredients and intended for a priori controlled release obey kinetics of the order of one-half (½) corresponding to a proportionality between the quantity released and the square root of time. Shea butter in nanoparticulate forms has thus enabled us to considerably prolong the release of griseofulvin.


Keywords: Nanoparticles; Shea Butter; Inflammation; Griseofulvin.

Keywords: Nanoparticles, Shea Butter, Inflammation, Griseofulvin

Downloads

Download data is not yet available.

Author Biography

Moussa Diop, Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal

Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie  Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal

References

1. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release Off J Control Release Soc. 2004; 99(1):53-62. doi:10.1016/j.jconrel.2004.06.015
2. Chen F, Ehlerding EB, Cai W. Theranostic nanoparticles. J Nucl Med Off Publ Soc Nucl Med. 2014; 55(12):1919-1922. doi:10.2967/jnumed.114.146019
3. Luengo J, Weiss B, Schneider M, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol. 2006; 19(4):190-197. doi:10.1159/000093114
4. Müller-Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2004; 58(2):343-356. doi:10.1016/j.ejpb.2004.03.028
5. Ting WW, Vest CD, Sontheimer RD. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int J Dermatol. 2004; 43(7):538-547. doi:10.1111/j.1365-4632.2004.02147.x
6. Demetzos C. Application of Nanotechnology in Drug Delivery and Targeting. In: Demetzos C, ed. Pharmaceutical Nanotechnology: Fundamentals and Practical Applications. Springer; 2016:77-145. doi:10.1007/978-981-10-0791-0_4
7. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine Nanotechnol Biol Med. 2010; 6(1):9-24. doi:10.1016/j.nano.2009.04.008
8. Shrivastava P, Vyas S, Sharma R, et al. 20 - Nanotechnology for oral drug delivery and targeting. In: Mozafari M, ed. Nanoengineered Biomaterials for Advanced Drug Delivery. Woodhead Publishing Series in Biomaterials. Elsevier; 2020:473-498. doi:10.1016/B978-0-08-102985-5.00020-6
9. Sutradhar KB, Amin ML. Nanotechnology in Cancer Drug Delivery and Selective Targeting. ISRN Nanotechnology. doi:https://doi.org/10.1155/2014/939378
10. Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO. Nanotechnology for COVID-19: Therapeutics and Vaccine Research. ACS Nano. 2020; 14(7):7760-7782. doi:10.1021/acsnano.0c04006
11. Chowdhury A, Kunjiappan S, Panneerselvam T, Somasundaram B, Bhattacharjee C. Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. Int Nano Lett. 2017; 7(2):91-122. doi:10.1007/s40089-017-0208-0
12. Din F ud, Aman W, Ullah I, et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 2017; 12:7291-7309. doi:10.2147/IJN.S146315
13. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021; 20(2):101-124. doi:10.1038/s41573-020-0090-8
14. Mohamed S, El-Sakhawy M, Sakhawy M. Polysaccharides, Protein and Lipid -Based Natural Edible Films in Food Packaging: A Review. Carbohydr Polym. 2020;238:116178. doi:10.1016/j.carbpol.2020.116178
15. Ribeiro LNM, Alcântara ACS, Rodrigues da Silva GH, et al. Advances in Hybrid Polymer-Based Materials for Sustained Drug Release. International Journal of Polymer Science. doi:https://doi.org/10.1155/2017/1231464
16. Thioune O, Dieng SM, Fall ABK, Diop M. Contribution of Nanotechnology In the Improvement of the Anti-Inflammatory activity of Shea butter. Published online 2020.
17. Yang S-J, Lin F-H, Tsai H-M, et al. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials. 2011; 32(8):2174-2182. doi:10.1016/j.biomaterials.2010.11.039
18. Yhee JY, Son S, Kim SH, Park K, Choi K, Kwon IC. Self-assembled glycol chitosan nanoparticles for disease-specific theranostics. J Control Release Off J Control Release Soc. 2014; 193:202-213. doi:10.1016/j.jconrel.2014.05.009
19. Feng S-S. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomed. 2006; 1(3):297-309. doi:10.2217/17435889.1.3.297
20. Karlsson J, Vaughan HJ, Green JJ. Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments. Annu Rev Chem Biomol Eng. 2018;9:105-127. doi:10.1146/annurev-chembioeng-060817-084055
21. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 2011; 9:55. doi:10.1186/1477-3155-9-55
22. Campani V, Giarra S, De Rosa G. Lipid-based core-shell nanoparticles: Evolution and potentialities in drug delivery. OpenNano. 2018; 3:5-17. doi:10.1016/j.onano.2017.12.001
23. Zhang M, Yang C, Yan X, Sung J, Garg P, Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Adv Ther. 2019; 2(12):1900129. doi:https://doi.org/10.1002/adtp.201900129
24. Dieng SM, Anton N, Bouriat P, et al. Pickering nano-emulsions stabilized by solid lipid nanoparticles as a temperature sensitive drug delivery system. Soft Matter. 2019; 15(40):8164-8174. doi:10.1039/C9SM01283D
25. Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285-308. doi:10.1016/j.ejpb.2018.10.017
26. Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Curr Med Chem. 2020; 27(22):3623-3656. doi:10.2174/0929867326666190624155938
27. Kanwar R, Rathee J, Salunke DB, Mehta SK. Green Nanotechnology-Driven Drug Delivery Assemblies. ACS Omega. 2019; 4(5):8804-8815. doi:10.1021/acsomega.9b00304
28. Katouzian I, Faridi Esfanjani A, Jafari SM, Akhavan S. Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients. Trends Food Sci Technol. 2017; 68:14-25. doi:10.1016/j.tifs.2017.07.017
29. Thioune O, Fall A, Dieng SM, Moussa D. Focus On the Use of Shea Butter as Excipient For Ointment. Am J PharmTech Res. 2019; 9:254-266. doi:10.46624/ajptr.2019.v9.i6.022
30. Sène M, Barboza FS, Sarr A, Fall AD, Ndione Y, Y GYS. Healing and topical anti-inflammatory activities of the total aqueous bark extract of Combretum glutinosum Perr. (Combretaceae). J Med Plants Res. 2020; 14(5):215-224. doi:10.5897/JMPR2019.6879
31. Tardat-henry M, Beaudry JP. Librairie Lavoisier. Published 1992. Accessed February 25, 2021. https://www.lavoisier.fr/livre/environnement/chimie-des-eaux-2-ed/tardat-henry/descriptif_2267056
32. Alander J. Shea butter - a multifunctional ingredient for food and cosmetics. LIPID Technol. 2004; 16:202-205.
33. Maranz S, Wiesman Z, Garti N. Phenolic Constituents of Shea (Vitellaria paradoxa) Kernels. J Agric Food Chem. 2003; 51(21):6268-6273. doi:10.1021/jf034687t
34. Nurah OT, Julius IU. Optimization of Aqueous Extraction Conditions of Unrefined Shea Butter Using Response Surface Methodology. Am J Food Nutr. 2018; 6(4):108-114. doi:10.12691/ajfn-6-4-3
35. kapseu K, J NY, M P, M D, J D. Fatty acids and triglycerides of Cameroon shea butter. Riv Ital Delle Sostanze Grasse. 2001; 78(1):31-34.
36. Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta BBA - Biomembr. 2002; 1564(1):21-30. doi:10.1016/S0005-2736(02)00401-7
37. Hansen S, Lehr C-M. Nanoparticles for transcutaneous vaccination. Microb Biotechnol. 2012; 5(2):156-167. doi:https://doi.org/10.1111/j.1751-7915.2011.00284.x
38. Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011; 63(6):470-491. doi:10.1016/j.addr.2011.01.012
Crossmark
Statistics
467 Views | 446 Downloads
How to Cite
1.
Dieng S, Séne M, Fall ABK, Diop M, Sy PM, Diouf LAD, Djiboune AR, Soumboundou M, Mbaye G, Diarra M, Thioune O. Formulation of shea butter Nanoparticle containing griseofulvin: a combination of antifungal and anti-inflammatory treatments. JDDT [Internet]. 15Apr.2021 [cited 19May2024];11(2-S):59-5. Available from: https://jddtonline.info/index.php/jddt/article/view/4796